Cystoliberin | Home Page | Right Strategy for Cystitis Cystoliberin Move

Cystoliberin^® is with you in
your lower urinary tract infections.

Its efficacy has been clinically proven.

More

It can be recommended alone or in combination with antibiotics.

LOWER URINARY TRACT INFECTION

What Is Cystitis?

Cystitis is an inflammation of the bladder.

A woman's lifetime risk of having a urinary tract infection is 60,4.*

* Foxman,B.(2014).Urinary Tract Infection Syndromes,Infectious Disease Clinics of North America,28(1),1-13. doi:10.1016//j.idc.2013.09.003*

//cystoliberin.com/wp-content/uploads/2021/09/sistit_nedir_kadin-ss.png

LOWER URINARY TRACT INFECTION

What Is Cystitis?

Cystitis is an inflammation of the bladder.

A woman's lifetime risk of having a urinary tract infection is 60,4*

* Foxman,B.(2014).Urinary Tract Infection Syndromes,Infectious Disease Clinics of North America,28(1),1-13. doi:10.1016//j.idc.2013.09.003*

LOWER URINARY TRACT INFECTION

What are the symptoms of cystitis?

Frequent Urination,
Urgency To Urinate

Urinary Incontinence

(Passing Urine)

Pain In The Lower Abdomen

Feeling Pain When Urinating

Fatique

To Urinate At Night

4 Million Female Patients

Around
150 million cases of urinary
tract infection develop annually worldwide.

%50

One of every two women,
urinary tract infection recurs.

Ayten Kadanalı: Üriner Sistem Enfeksiyonları, EAJM 38, 119-123*

LOWER URINARY TRACT INFECTION

Women between 22-55 constitute 75% of cystitis patients.

//cystoliberin.com/wp-content/uploads/2021/11/sistit-tablo-en.png

Evaluation of the dra guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women Jakhongir F. Alidjanov, Kurt G. Naber, Adrian Pilatz,Abdukhamid Radzhabov, Musluhuddin Zamuddinov, András Magyar, Peter Tenke&Florian M. WagenlehnerWorld Journal of Urology volume38,pages63–72(2020)*

LOWER URINARY TRACT INFECTION

Women between 22-55 constitute 75% of cystitis patients.

Evaluation of the dra guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women Jakhongir F. Alidjanov, Kurt G. Naber, Adrian Pilatz,Abdukhamid Radzhabov, Musluhuddin Zamuddinov, András Magyar, Peter Tenke&Florian M. WagenlehnerWorld Journal of Urology volume38,pages63–72(2020)*

In The Treatment Of Cystitis

Problems That May Arise After Antibiotic Use

Antibiotic Resistance

Antibiotic resistance can develop in bacteria after the use of antibiotics. As a result, the effectiveness of antibiotic treatments decreases. This is why it is important to avoid unnecessary antibiotic use.

Gut Microbiota

The use of antibiotics damages the gut microbiota. The gut microbiota cannot return to its natural balance for about two years after antibiotic use.

Vaginal Yeast Infection

After antibiotic treatment, the vaginal flora is damaged. In deteriorating flora, opportunistic organisms reproduce more easily. Antibiotic use can trigger vaginal yeast infection, in which women often have problems, negatively affect their quality of life and are difficult to treat.

WHY

CYSTOLIBERIN^®?

Its effectiveness is clinically proven; it helps the patient and doctor in lower urinary tract infections with its active components, which can be used in the treatment process or for protective purposes.

You can safely use.

Safe

Safe for gut microbiota, beneficial bacteria and vaginal flora.

Proven

Its effectiveness in lower urinary tract infection has been clinically proven

Ease Of Use

It provides easy absorption with its suspension form. It is suitable for use by both adults and children.

Combined Formulation

It is the first combined formulation in Turkey. It provides fast and effective support for lower urinary tract infection with its multi-component technology consisting of 6 different ingredients.

Is Standardized

It has standardized contents. The amount of active ingredient is determined for each dose.

Does Not Cause Side Effects

It is suitable for long-term use. It does not cause antibiotic resistance.

THE PATH OF COURAGE TO FUTURE HEALTHCARE

SETONDA^®

Our products, produced in our production facility in Barcelona, Spain, offer safe and effective treatments at different stages of the disease, thanks to its multi-component technology. The standardization of the production process starting from active active ingredient production is carefully and precisely followed and documented in accordance with the European Union Regulations with quality control and quality assurance systems.

setonda.com

Setonda Laboratorio

For more information visit the websites of our products.

Sign in to Canimed

Hello, Friend!

Ask a question

section-87a89c7

About

LOWER URINARY TRACT INFECTION

What Is Cystitis?

mobil-ust

LOWER URINARY TRACT INFECTION

What Is Cystitis?

About

LOWER URINARY TRACT INFECTION

What are the symptoms of cystitis?

Frequent Urination,Urgency To Urinate

Urinary Incontinence (Passing Urine)

Pain In The Lower Abdomen

Feeling Pain When Urinating

Fatique

To Urinate At Night

section-f2f9e70

4 Million Female Patients

Around150 million cases of urinary tract infection develop annually worldwide.

About

One of every two women,urinary tract infection recurs.

desktop-graphic

LOWER URINARY TRACT INFECTION

Women between 22-55 constitute 75% of cystitis patients.

desktop-graphic-mobile

LOWER URINARY TRACT INFECTION

Women between 22-55 constitute 75% of cystitis patients.

uclu-icon

In The Treatment Of Cystitis

Problems That May Arise After Antibiotic Use

Antibiotic Resistance

Gut Microbiota

Vaginal Yeast Infection

why cys

WHY

CYSTOLIBERIN®?

Features

Safe

Proven

Ease Of Use

Combined Formulation

Is Standardized

Does Not Cause Side Effects

About

THE PATH OF COURAGE TO FUTURE HEALTHCARE

SETONDA®

About

Setonda Laboratorio

Frequent Urination,
Urgency To Urinate

Urinary Incontinence

(Passing Urine)

Around
150 million cases of urinary
tract infection develop annually worldwide.

One of every two women,
urinary tract infection recurs.

CYSTOLIBERIN^®?

SETONDA^®